These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12467380)

  • 1. Matrix metalloproteinases and neuroinflammation in multiple sclerosis.
    Rosenberg GA
    Neuroscientist; 2002 Dec; 8(6):586-95. PubMed ID: 12467380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix degradation by metalloproteinases and central nervous system diseases.
    Lukes A; Mun-Bryce S; Lukes M; Rosenberg GA
    Mol Neurobiol; 1999 Jun; 19(3):267-84. PubMed ID: 10495107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Update on the Role of Matrix Metalloproteinases in the Pathogenesis of Multiple Sclerosis.
    Boziki M; Grigoriadis N
    Med Chem; 2018 Feb; 14(2):155-169. PubMed ID: 28875862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND.
    Förster C; Kahles T; Kietz S; Drenckhahn D
    J Physiol; 2007 May; 580(Pt.3):937-49. PubMed ID: 17317742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases in inflammatory demyelination: targets for treatment.
    Kieseier BC; Seifert T; Giovannoni G; Hartung HP
    Neurology; 1999 Jul; 53(1):20-5. PubMed ID: 10408531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
    Leppert D; Lindberg RL; Kappos L; Leib SL
    Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases in cerebrovascular disease.
    Mun-Bryce S; Rosenberg GA
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1163-72. PubMed ID: 9809504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Netrin 1 regulates blood-brain barrier function and neuroinflammation.
    Podjaski C; Alvarez JI; Bourbonniere L; Larouche S; Terouz S; Bin JM; Lécuyer MA; Saint-Laurent O; Larochelle C; Darlington PJ; Arbour N; Antel JP; Kennedy TE; Prat A
    Brain; 2015 Jun; 138(Pt 6):1598-612. PubMed ID: 25903786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of central nervous system barriers in multiple sclerosis.
    Alvarez JI; Cayrol R; Prat A
    Biochim Biophys Acta; 2011 Feb; 1812(2):252-64. PubMed ID: 20619340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
    Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
    Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L; Annunziata P; Sessa E; Bramanti P
    J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
    Ummenthum K; Peferoen LA; Finardi A; Baker D; Pryce G; Mantovani A; Bsibsi M; Bottazzi B; Peferoen-Baert R; van der Valk P; Garlanda C; Kipp M; Furlan R; van Noort JM; Amor S
    Eur J Immunol; 2016 Mar; 46(3):701-11. PubMed ID: 26576501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions.
    Alvarez JI; Saint-Laurent O; Godschalk A; Terouz S; Briels C; Larouche S; Bourbonnière L; Larochelle C; Prat A
    Neurobiol Dis; 2015 Feb; 74():14-24. PubMed ID: 25448765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis].
    Kurzepa J; Bartosik-Psujek H; Suchozebrska-Jesionek D; Rejdak K; Stryjecka-Zimmer M; Stelmasiak Z
    Neurol Neurochir Pol; 2005; 39(1):63-7. PubMed ID: 15735992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteases activity and ultrastructural changes in the early phase of experimental allergic encephalomyelitis. The effect of oral treatment with spinal cord hydrolysate [correction of hydrolisate] proteins in Lewis rat. The pilot study.
    Kwiatkowska-Patzer B; Walski M; Frontczak-Baniewicz M; Zalewska T; Baranowska B; Lipkowski AW
    Folia Neuropathol; 2004; 42(2):107-11. PubMed ID: 15266785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain.
    Gasche Y; Soccal PM; Kanemitsu M; Copin JC
    Front Biosci; 2006 May; 11():1289-301. PubMed ID: 16368516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases in neuroinflammation.
    Rosenberg GA
    Glia; 2002 Sep; 39(3):279-91. PubMed ID: 12203394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathology and pathogenesis of multiple sclerosis from the viewpoint of neurologic disease research].
    Seitelberger F
    Wien Med Wochenschr; 1985 Jan; 135(1-2):6-7. PubMed ID: 3976241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.